The Chemours Company
Focused on safe and sustainable manufacturing of titanium dioxide and fluoroproducts.
- Chemical
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor | €0.0 Valuation: €0.0 0.1x EV/Revenue 0.4x EV/EBITDA | round | |
| investor | €0.0 | round | |
* | N/A | $600m | Post IPO Debt |
| Total Funding | 000k | ||
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | (10 %) | 28 % | 7 % | (11 %) | (4 %) | 2 % | 4 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 17 % | 19 % | 18 % | 4 % | 14 % | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 4 % | 10 % | 9 % | (4 %) | 1 % | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 2 % | 2 % | 2 % | 2 % | 2 % | - | - |
Source: Company filings or news article, Equity research estimates
The Chemours Company emerged in July 2015 as a spin-off from the renowned chemical giant, DuPont. This strategic move was designed to allow Chemours to focus on its core strengths in the chemical industry, particularly in the production of titanium dioxide, refrigerants, and the well-known Teflon brand. The spin-off marked a significant milestone, positioning Chemours as an independent entity with a clear mission to innovate and lead in its specialized markets.
Though Chemours was not founded by individual entrepreneurs in the traditional sense, its creation was spearheaded by DuPont's leadership team, who envisioned a company that could operate with greater agility and focus. The leadership team, including CEO Mark Vergnano, played a crucial role in steering Chemours through its early days as a standalone company.
One of the pivotal moments in Chemours' journey was its initial public offering (IPO) in 2015, which allowed the company to establish its financial independence and invest in growth opportunities. This move was crucial for Chemours to expand its market presence and enhance its product offerings.
Since its inception, Chemours has faced challenges typical of a new company, including market fluctuations and environmental regulations. However, it has consistently demonstrated resilience and adaptability, focusing on sustainable solutions and innovative products. Today, Chemours stands as a testament to strategic corporate restructuring, with a commitment to delivering value through chemistry.
